Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Zynex Inc. (ZYXI) - free report >>
Electronic Arts Inc. (EA) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zynex Inc. (ZYXI) - free report >>
Electronic Arts Inc. (EA) - free report >>
Image: Bigstock
New Strong Buy Stocks for May 4th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Reed's, Inc. (REED - Free Report) : This company that develops, manufactures, and sells natural hand-crafted beverages has seen the Zacks Consensus Estimate for its current year earnings increasing 30.4% over the last 60 days.
Reeds, Inc. Price and Consensus
Reeds, Inc. price-consensus-chart | Reeds, Inc. Quote
Electronic Arts Inc. (EA - Free Report) : This company that develops, markets, publishes, and distributes games, content, and services for game consoles, PCs, mobile phones, and tablets has seen the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.
Electronic Arts Inc. Price and Consensus
Electronic Arts Inc. price-consensus-chart | Electronic Arts Inc. Quote
Zynex, Inc. (ZYXI - Free Report) : This company that manufactures, and markets medical devices has seen the Zacks Consensus Estimate for its current year earnings increasing 14.3% over the last 60 days.
Zynex Inc. Price and Consensus
Zynex Inc. price-consensus-chart | Zynex Inc. Quote
CytomX Therapeutics, Inc. (CTMX - Free Report) : This oncology-focused biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 28.8% over the last 60 days.
CytomX Therapeutics, Inc. Price and Consensus
CytomX Therapeutics, Inc. price-consensus-chart | CytomX Therapeutics, Inc. Quote
Intec Pharma Ltd. : This clinical stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 45.9% over the last 60 days.
Intec Pharma Ltd. Price and Consensus
Intec Pharma Ltd. price-consensus-chart | Intec Pharma Ltd. Quote
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>